Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Cohen

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
JCO Precision Oncology|December 12, 2023
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based TherapyIda Micaily, Edik M Blais, Randi Carhart, et al.
JNCI Cancer Spectrum|September 6, 2021
Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon CancerFrank A Sinicrope, Qian Shi, Thomas C Smyrk, et al.
Cancer Research|June 17, 2005
Global gene expression profiling of circulating tumor cellsDenis A Smirnov, Daniel R Zweitzig, Bradley W Foulk, et al.
The Oncologist|January 21, 2016
Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal CancerLawrence Leichman, Susan Groshen, Bert H O'Neil, et al.
British Journal of Cancer|March 11, 2020
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trialsNamrata Vijayvergia, Arvind Dasari, Mengying Deng, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancerAndrew S Kennedy, David Ball, Steven J Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancerSteven J Cohen, Cornelis J A Punt, Nicholas Iannotti, et al.
Journal of Gastrointestinal Oncology|December 24, 2015
Hepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastasesAndrew S Kennedy, David S Ball, Steven J Cohen, et al.
Clinical Colorectal Cancer|November 7, 2015
Safety and Efficacy of Radioembolization in Elderly (≥ 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal CancerAndrew S Kennedy, David S Ball, Steven J Cohen, et al.
Journal of Gastrointestinal Oncology|April 2, 2015
Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheresAndrew S Kennedy, David Ball, Steven J Cohen, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
JCO Precision Oncology|December 12, 2023
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based TherapyIda Micaily, Edik M Blais, Randi Carhart, et al.
JNCI Cancer Spectrum|September 6, 2021
Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon CancerFrank A Sinicrope, Qian Shi, Thomas C Smyrk, et al.
Cancer Research|June 17, 2005
Global gene expression profiling of circulating tumor cellsDenis A Smirnov, Daniel R Zweitzig, Bradley W Foulk, et al.
The Oncologist|January 21, 2016
Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal CancerLawrence Leichman, Susan Groshen, Bert H O'Neil, et al.
British Journal of Cancer|March 11, 2020
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trialsNamrata Vijayvergia, Arvind Dasari, Mengying Deng, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancerAndrew S Kennedy, David Ball, Steven J Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancerSteven J Cohen, Cornelis J A Punt, Nicholas Iannotti, et al.
Journal of Gastrointestinal Oncology|December 24, 2015
Hepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastasesAndrew S Kennedy, David S Ball, Steven J Cohen, et al.
Clinical Colorectal Cancer|November 7, 2015
Safety and Efficacy of Radioembolization in Elderly (≥ 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal CancerAndrew S Kennedy, David S Ball, Steven J Cohen, et al.
Journal of Gastrointestinal Oncology|April 2, 2015
Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheresAndrew S Kennedy, David Ball, Steven J Cohen, et al.
Pageof 11